13F filing recap · Q4 2017
What did Chou Associates buy in Q4 2017?
Reported stock-position changes between this filing and the previous one.
Stock value
$229.00M
Positions
22
Estimated turnover
46.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Reduced positions
RFPResolute Forest Products Inc$50.80Mreported value-366.6K shares-7.4%JPMJPMorgan Chase & Co$11.09Mreported value-199.4K shares-54.4%VRXValeant Pharmaceuticals International, Inc.$3.10Mreported value-2.90M shares-95.1%SDSandridge Energy, Inc.$2.86Mreported value-20.7K shares-13.2%BAC WS ABank of America Corp$2.63Mreported value-287.3K shares-65.8%ENDPEndo International Plc$620.0Kreported value-870.0K shares-91.6%RYAAYRyanair Holdings Plc$477.0Kreported value-12.0K shares-72.4%OSTKOverstock.com Inc$425.0Kreported value-280.0K shares-97.7%TEVATeva Pharmaceutical Industries Limited$284.0Kreported value-490.0K shares-97.0%